Movie 3.

The beating heart of a Xenopus embryo injected with fbrsl1 sp MO. Four-cell-stage embryos were injected in one dorsal blastomere with 7.5 ng fbrsl1 sp MO in combination with 50 pg mGFP RNA as a lineage tracer. The embryos were anesthetized with 0.1x MBS (modified Barth's saline) containing 0.01% benzocaine. Beating hearts were recorded at stage 44. A representative embryo is shown from the ventral side. The heart is malformed and has a smaller ventricle, but is able to beat. The blood flow is not visible.

Fbrsl1 is required for heart development in Xenopus laevis and de novo variants in FBRSL1 can cause human heart defects

Hanna Berger, Sarah Gerstner, Marc-Frederik Horstmann, Silke Pauli, and Annette Borchers

Disease Models and Mechanisms 2024. 17:None-None; doi: 10.1242/dmm.050507